The device is already being used in Israel, Spain, and the UK. Now insurers are accepting it to be deducted from insurance payments. If they are going to increase the number of treatment centers and train more doctors to use it, they need more capital. It is an incredible capital-heavy process to expand in 38 countries. Also, the share price rose 4.8% in 2024 so suspending trade to raise more capitalis pretty good news.
News: OSL Oncosil Medical Seeks Trading Halt, page-22
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.3¢ | $9.782K | 752.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 11636360 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 4307472 | 9 |
View Market Depth
| Last trade - 14.13pm 02/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |